Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes

British Journal of Ophthalmology

Volumn 81, Issue 10, 1997, Pages 919-926

  Chen, Ying Shan ^a   Hackett, Sean F ^a   Schoenfeld, Carl Ludwig ^a   Vinores, Melissa A ^a   Vinores, Stanley A ^a   Campochiaro, Peter A ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ARTICLE; AUTOPSY; CELL CULTURE; CONTROLLED STUDY; DISEASE COURSE; EPIRETINAL MEMBRANE; GLIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROTEIN LOCALIZATION; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030782147     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.81.10.919     Document Type: Article

References (65)

1. Clarkson JG, Green WR, Masof D. A histopathologic review of 168 cases of preretinal membrane. Am J Ophthalmol 1977;84:1-17.
2. Hiscott PS, Grierson I, McLeod D. Retinal pigment epithelial cells in epiretinal membranes: an immunohistochemical study. Br J Ophthalmol 1984;68:708-15.
3. Hiscott PS, Grierson I, Trombetta CJ, Rahi AHS, Marshall J, McLeod D. Retinal and epiretinal glia: an immunohistochemical study. Br J Ophthalmol 1985;68:698-707.
4. Kampik A. Kenyon KR, Michels RG, Green WR, de la Cruz ZC. Epiretinal and vitreous membranes: comparative study of 56 cases. Arch Ophthalmol 1981;99:1445-54.
5. Vinores SA, Campochiaro PA, Conway BP. Ultrastructural and electronimmunocytochemical characterization of cells in epiretinal membranes. Invest Ophthalmol Vis Sci 1990;31:14-28.
6. Cowley M, Conway BP, Campochiaro PA, Kaiser D, Gaskin H. Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol 1989;107:1147-51.
7. The Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983;90:121-5.
8. Campochiaro PA, Glaser BM. A retina-derived stimulator(s) of retinal pigment epithelial cell and astrocyte proliferation. Exp Eye Res 1986;43:449-57.
9. Campochiaro PA, Bryan JA, III, Conway BP, Jaccoma EH. Intravitreal chemotactic and mitogenic activity. Implication of blood-retinal barrier breakdown. Invest Ophthalmol Vis Sci 1986;27(Suppl):188.
10. Sen HA, Campochiaro PA. Intravitreous injection of adenosine or its agonists cause breakdown of the blood-retinal barrier. Arch Ophthalmol 1989;107:1364-7.
11. Campochiaro PA, Hackett SF, Vinores SA, Freund J, Csaky C, LaRochelle W, et al. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. J Cell Sci 1994;107:2459-69.
12. Plate KH, Breier G, Welch HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992;359:845-8.
13. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced byhypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-5.
14. Adamis AP, Miller JS, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994;118:445-50.
15. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-7.
16. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995;92:10457-61.
17. Malecaze F, Clamens S, Simorre-Pinatel V, Mathis A, Chollet P, Favard C, et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol 1994;112:1476-82.
18. Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, et al. Vascular endothelial growth factor/ vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Path 1994;145:574-84.
19. Pe'er J, Shweiki D, Itin A, Heme I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 1995;72:638-15.
20. Pe'er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 1996;80:241-5.
21. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995;92:905-9.
22. DeVries C, Esobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989-91.
23. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992;187:1579-86.
24. Quinn TP, Peters KG, DeVries C, Ferrara N, Williams LT. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 1993;90:7533-7.
25. Sivalingam A, Kenney J, Brown GC, Benson WE, Donoso L. Blast fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1990;108:869-72.
26. Hanneken A, deJuan E, Jr, Lutty GA, Fox GM, Schiffer S, Hjelmeland LM. Altered distribution of basic fibroblast growth factor in diabetic retinopathy. Arch Ophthalmol 1991;109:1005-11.
27. Pournaras CJ, Tsacopoulos M, Strommer K, Gilodi N, Leuenberger PM. Scatter photocoagulation restores tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs. Ophthalmology 1990;97:1329-33.
28. Robbins SG, Mixon KN, Wilson DJ, Hart CE, Robertson JE, Westra I, et al. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci 1994;35:3649-63.
29. Vinores SA, Henderer JD, Mahlow J, Chiu C, Derevjanik NL, LaRochelle W, et al. Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells. Exp Eye Res 1995;60:607-19.
30. Campochiaro PA, Hackett SF, Vinores SA. Growth factors in the retina and retinal pigmented epithelium. Prog Retinal Eye Res 1996;15:547-67.
31. Barthel LK, Raymond PA. Improved method for obtaining 3-μm cryosections for immunocytochemistry. J Histochem Cytochem 1990;38:1383-8.
32. Campochiaro PA, Jerdan JA, Glaser BM. The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro. Invest Ophthalmol Vis Sci 1986;27: 1615-21.
33. Leschey KH, Hackett SF, Singer JH, Campochiaro PA. Growth factor responsiveness of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1990;31:839-46.
34. Vinores SA, Campochiaro PA, McGehee R, Orman W, Hackett SF, Hjelmeland LM. Ultrastructural immunocytochemical changes in RPE, retinal glia, and fibroblasts in vitreous culture. Invest Ophthalmol Vis Sci 1990;31:2529-45.
35. Lutty GA, Merges C, Threlkeld A, Crone C, McLeod D. Heterogeneity in localization of isoforms of TGF-β in human retina, vitreous and choroid. Invest Ophthalmol Vis Sci 1993;34:477-87.
36. Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblast and smooth muscle cells is due to PDGFAA. Science 1989; 243:393-6.
37. LaRochelle WJ, Robbins KC, Arinson SA. Immunochemical localization of the epitope for a monoclonal antibody that neutralizes human platelet-derived growth factor mitogenic activity. Mol Cell Biol 1989;9:3538-42.
38. Lutty GA, Merges C, Crone S, McLeod DS. Immunohistochemical insights into sickle cell retinopathy. Curr Eye Res 1994;13:125-38.
39. Reilly TM, Taylor DS, Herblin WF, Thoolen MJ, Chiu AT, Watson DW, et al. Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo. Biochetn Biophys Res Com 1989; 164:736-43.
40. Vinores SA, Herman MM, Hackett SF, Campochiaro PA. A morphological and immunohistochemical study of human retinal pigment epithelial cells, retinal glia, and fibroblasts grown on Gelfoam matrix in an organ culture system. A comparison of structural and nonstructural proteins and their application to cell type identification. Graefes Arch Clin Exp Ophthalmol 1993;231:279-88.
41. Vinores SA, Derevjanik NL, Mahlow J, Haller JA, DeJuan E, Frankfurter A, et al. Class III β-tubulin in human retinal pigment epithelial cells in culture and in epiretinal membranes. Exp Eye Res 1995;60:385-400.
42. Vinores SA, Vinores MA, Chiu C, Woerner TM, Campochiaro PA. Double-labelling for keratin and class III β-tubulin within cultured retinal pigment epithelial cells: comparison of chromogens to yield maximum resolution of two structural proteins within the same cell. J Histotechnol 1997;20:19-25.
43. 1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells. J Biol Chem 1996;271:11500-5.
44. Berard M, Sordello S, Ortega N, Carrier J-L, Peyri N, Wassef M, et al. Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. Am J Pathol 1997;150: 1315-26.
45. Charmock-Jones DS, Sharkey A, Boocock CA, Ahmed A, Plevin R, Ferrara N, et al. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod 1994;51:524-30.
46. Ahmed A, Li XF, Dunk L, Whittle MJ, Rushton DI, Rollason T. Colocalization of vascular endothelial growth factor and its flt-1 receptor in human placenta. Growth Factors 1995;12:235-13.
47. Chomczynski P, Sacchi N. Single step of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
48. Jakeman LB, Winer J, Bennett GL, Altar CA, Ferrara N. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. Clin Invest 1992;89:244-53.
49. Storksen NF, Harsh GR, Gibbs VC, Williams LT. Regulated expression of the platelet-derived growth factor A chain gene in microvascular endothelial cells. J Biol Chem 1987; 262:14381-4.
50. Mudhar HS, Pollock RA, Wang C, Stiles CD, Richardson WD. PDGF and its receptors in the developing rodent retina and optic nerve. Development 1993;118:539-52.
51. Frank RN, Amin RH, Eliott D, Puklin JE, Abrams GW. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol 1996;122:393-403.
52. Adamis AP, Shima DT, Yeo K-T, Yeo TK, Brown LF, Berse B, et al. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Comm 1993;193:631-8.
53. Hata Y, Nakagawa K, Ishibashi T, Inomata H, Ueno H, Sueishi K. Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis. Virchows Archiv 1995;426:479-86.
54. Kvanta A. Expression and regulation of vascular endothelial growth factor in choroidal fibroblasts. Curr Eye Res 1995;14:1015-20.
55. Lopez PF, Sippy BD, Lambert HM, Thack AB, Hinton DR. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996;37:855-68.
56. Ozaki H, Hayashi H, Vinores SA, Moromisato Y, Campochiaro PA, Oshima K. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res 1997;64:505-17.
57. Vinores SA, Küchle M, Mahlow J, Chiu C, Green WR, Campochiaro PA. Blood-ocular barrier breakdown in eyes with ocular melanoma: a potential role for vascular endothelial growth factor. Am J Pathol 1995;147:1289-97.
58. Vinores SA, Youssri AI, Luna JD, Chen Y-S, Bhargave S, Vinores MA, et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 1997;12:99-109.
59. Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K, et al. Intravenous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996; 103:1820-8.
60. Behzadian MA, Wang XL, Jiang B, Caldwell RB. Angiostatic role of astrocytes-suppression of vascular endothelial cell growth by TGF-β and other inhibitory factor(s). Glia 1995;15:480-90.
61. Yang X, Cepko CL. Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. J Neurosci 1996; 16:6089-99.
62. Bednarz J, Weich HA, Rodokanaki-von Schrenck A, Engelmann K. Expression of genes coding growth factors and growth factor receptors in differentiated and dedifferentiated human corneal endothelial cells. Cornea 1995;14:372-81.
63. Takahashi T, Shirasawa T, Miyake K, Yahagi Y, Maruyama N, Kasahara N, et al. Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells. Biochem Biophys Res Comm 1995;209:218-26.
64. Cohen T, Gitay-Goren H, Sharon R, Shibuya M, Halaban R, Levi BZ, et al. VEGF 121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparin sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem 1995;270:11322-6.
65. Guerrin M, Moukadiri H, Chollet P, Moro F, Dutt K, Malecaze F, et al. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol 1995;164:385-94.